Terms: = Lymphoma AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
624 results:
1. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract] [Full Text] [Related]
2. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
Xiong J; Cheng S; Gao X; Yu SH; Dai YT; Huang XY; Zhong HJ; Wang CF; Yi HM; Zhang H; Cao WG; Li R; Tang W; Zhao Y; Xu PP; Wang L; Zhao WL
Signal Transduct Target Ther; 2024 Mar; 9(1):62. PubMed ID: 38448403
[TBL] [Abstract] [Full Text] [Related]
3. treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
[TBL] [Abstract] [Full Text] [Related]
4. An anti-CD19/ctla-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.
Prinz LF; Riet T; Neureuther DF; Lennartz S; Chrobok D; Hübbe H; Uhl G; Riet N; Hofmann P; Hösel M; Simon AG; Tetenborg L; Segbers P; Shimono J; Gödel P; Balke-Want H; Flümann R; Knittel G; Reinhardt HC; Scheid C; Büttner R; Chapuy B; Ullrich RT; Hallek M; Chmielewski MM
Cell Rep Med; 2024 Feb; 5(2):101421. PubMed ID: 38340727
[TBL] [Abstract] [Full Text] [Related]
5. A case report: Castleman disease treated by the trinity of internal and external treatment of "Fuzheng, phlegm-resolving, and detoxification method".
Yuan X; Fu H; Xu M; Shen W; Zhou W; Li X; Gan X
Medicine (Baltimore); 2024 Feb; 103(5):e37110. PubMed ID: 38306555
[TBL] [Abstract] [Full Text] [Related]
6. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma.
Pirosa MC; Stathis A; Zucca E
Hum Vaccin Immunother; 2024 Dec; 20(1):2309701. PubMed ID: 38299612
[TBL] [Abstract] [Full Text] [Related]
7. Therapy of Castleman's disease with siltuximab - case report and review of literature.
Adam Z; Zeman D; Chodacki A; Pour L; Horváth T; Benda P; Adamová Z; Krejčí M; Tomíška M; Boichuk I; Král Z
Klin Onkol; 2023; 37(4):320-329. PubMed ID: 38195387
[TBL] [Abstract] [Full Text] [Related]
8. Monomorphic epitheliotropic intestinal T-cell lymphoma involving the central nervous system: a rare case report with comprehensive autopsy neuropathological examinations.
Talabong DJA; Laguerre E; Chen NN; Zeng J
J Hematop; 2023 Sep; 16(3):155-160. PubMed ID: 38175405
[TBL] [Abstract] [Full Text] [Related]
9. Maintenance therapy for chronic lymphocytic leukaemia.
Lee CH; Wu YY; Huang TC; Lin C; Zou YF; Cheng JC; Chen PH; Jhou HJ; Ho CL
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013474. PubMed ID: 38174814
[TBL] [Abstract] [Full Text] [Related]
10. Pediatric-type follicular lymphoma in a Crohn's disease patient receiving anti-α4β7-integrin therapy: A case report.
Yerigeri K; Buhtoiarov I
World J Gastroenterol; 2023 Nov; 29(43):5865-5871. PubMed ID: 38074918
[TBL] [Abstract] [Full Text] [Related]
11. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
[TBL] [Abstract] [Full Text] [Related]
12. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
14. Mycosis fungoides with spongiosis: a case report.
Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
[TBL] [Abstract] [Full Text] [Related]
15. Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review.
Patt YS; Lahat A; David P; Patt C; Eyade R; Sharif K
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895160
[TBL] [Abstract] [Full Text] [Related]
16. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
[TBL] [Abstract] [Full Text] [Related]
17. Deletion of the inhibitory co-receptor ctla-4 enhances and invigorates chimeric antigen receptor T cells.
Agarwal S; Aznar MA; Rech AJ; Good CR; Kuramitsu S; Da T; Gohil M; Chen L; Hong SA; Ravikumar P; Rennels AK; Salas-Mckee J; Kong W; Ruella M; Davis MM; Plesa G; Fraietta JA; Porter DL; Young RM; June CH
Immunity; 2023 Oct; 56(10):2388-2407.e9. PubMed ID: 37776850
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature.
Nakao K; Nishikori M; Fujimoto M; Arima H; Haga H; Takaori-Kondo A
J Clin Exp Hematop; 2023 Jun; 63(2):132-138. PubMed ID: 37245973
[TBL] [Abstract] [Full Text] [Related]
19. Differential Response of Mycosis Fungoides Cells to Vorinostat.
Bordeaux ZA; Reddy SV; Lee K; Lu W; Choi J; Miller M; Roberts C; Pollizzi A; Kwatra SG; Kwatra MM
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175780
[TBL] [Abstract] [Full Text] [Related]
20. A Winning New Combination? Toward Clinical Application in Oncology.
Maqsood Q; Sumrin A; Iqbal M; Hussain N; Mahnoor M; Zafar Saleem M; Perveen R
Cancer Control; 2023; 30():10732748231175240. PubMed ID: 37166227
[TBL] [Abstract] [Full Text] [Related]
[Next]